tiprankstipranks
Helus Pharma (HELP)
NASDAQ:HELP
US Market
HELP
Helus Pharma
RESEARCH TOOLSreports

Helus Pharma (HELP) Ratios

2,500 Followers

Helus Pharma Ratios

HELP's free cash flow for Q4 2026 was C$0.00. For the 2026 fiscal year, HELP's free cash flow was decreased by C$ and operating cash flow was C$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Jun 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 13.78 ― 7.75 21.65 2.93
Quick Ratio
 13.78 ― 7.75 21.65 2.77
Cash Ratio
 12.06 ― 6.30 20.70 2.10
Solvency Ratio
 -7.69 ― -5.26 -7.71 -5.03
Operating Cash Flow Ratio
 -6.75 ― -4.73 -6.83 -5.72
Short-Term Operating Cash Flow Coverage
 0.00 ― 0.00 -236.39 0.00
Net Current Asset Value
C$ 206.72MC$ ―C$ 144.55MC$ 208.44MC$ 15.28M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 ― 0.00 <0.01 0.00
Debt-to-Equity Ratio
 0.00 ― 0.00 <0.01 0.00
Debt-to-Capital Ratio
 0.00 ― 0.00 <0.01 0.00
Long-Term Debt-to-Capital Ratio
 0.00 ― 0.00 0.00 0.00
Financial Leverage Ratio
 1.06 ― 1.09 1.03 1.12
Debt Service Coverage Ratio
 -40.94 ― 0.00 -269.55 0.00
Interest Coverage Ratio
 -40.87 ― 0.00 0.00 0.00
Debt to Market Cap
 0.00 ― 0.00 <0.01 0.00
Interest Debt Per Share
 0.07 ― 0.00 <0.01 0.00
Net Debt to EBITDA
 1.61 ― 0.95 2.66 0.32
Profitability Margins
Gross Profit Margin
0.00%―0.00%0.00%0.00%
EBIT Margin
0.00%―0.00%0.00%0.00%
EBITDA Margin
0.00%―0.00%0.00%0.00%
Operating Profit Margin
0.00%―0.00%0.00%0.00%
Pretax Profit Margin
0.00%―0.00%0.00%0.00%
Net Profit Margin
0.00%―0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%―0.00%0.00%0.00%
Net Income Per EBT
90.46%―100.00%100.00%84.31%
EBT Per EBIT
113.76%―79.04%99.04%92.18%
Return on Assets (ROA)
-42.95%―-43.75%-25.85%-74.28%
Return on Equity (ROE)
-61.09%―-47.70%-26.75%-83.01%
Return on Capital Employed (ROCE)
-44.20%―-60.35%-27.01%-112.02%
Return on Invested Capital (ROIC)
-44.20%―-60.35%-26.95%-112.02%
Return on Tangible Assets
-55.86%―-68.11%-35.64%-138.43%
Earnings Yield
-64.24%―-65.80%-5.27%-2.70%
Efficiency Ratios
Receivables Turnover
 0.00 ― 0.00 0.00 0.00
Payables Turnover
 0.00 ― 0.02 0.04 0.04
Inventory Turnover
 0.00 ― 0.00 0.00 0.20
Fixed Asset Turnover
 0.00 ― 0.00 0.00 0.00
Asset Turnover
 0.00 ― 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 ― 0.00 0.00 0.00
Cash Conversion Cycle
 0.00 ― -16.55K -8.44K -6.39K
Days of Sales Outstanding
 0.00 ― 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 ― 0.00 0.00 1.85K
Days of Payables Outstanding
 0.00 ― 16.55K 8.44K 8.24K
Operating Cycle
 0.00 ― 0.00 0.00 1.85K
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.57 ― -5.01 -0.37 -0.24
Free Cash Flow Per Share
 -2.62 ― -5.11 -0.38 -0.25
CapEx Per Share
 0.05 ― 0.10 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.02 ― 1.02 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
 -52.70 ― -51.53 -97.05 -86.94
Capital Expenditure Coverage Ratio
 -52.70 ― -51.53 -97.05 -86.94
Operating Cash Flow Coverage Ratio
 0.00 ― 0.00 -236.80 0.00
Operating Cash Flow to Sales Ratio
 0.00 ― 0.00 0.00 0.00
Free Cash Flow Yield
-100.80%―-60.06%-4.70%-3.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.32 ― -1.52 -18.98 -36.99
Price-to-Sales (P/S) Ratio
 0.00 ― 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 1.06 ― 0.72 5.08 30.71
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.49 ― -1.66 -21.29 -32.39
Price-to-Operating Cash Flow Ratio
 -2.66 ― -1.70 -21.50 -32.76
Price-to-Earnings Growth (PEG) Ratio
 0.35 ― -0.04 -0.01 0.76
Price-to-Fair Value
 1.06 ― 0.72 5.08 30.71
Enterprise Value Multiple
 0.24 ― -0.26 -16.20 -28.56
Enterprise Value
 -84.71M ― 36.91M 1.27B 1.46B
EV to EBITDA
 0.70 ― -0.26 -16.20 -28.56
EV to Sales
 0.00 ― 0.00 0.00 0.00
EV to Free Cash Flow
 0.76 ― -0.36 -18.29 -32.03
EV to Operating Cash Flow
 0.78 ― -0.36 -18.48 -32.40
Tangible Book Value Per Share
 4.87 ― 7.16 1.13 0.11
Shareholders’ Equity Per Share
 6.44 ― 11.73 1.57 0.26
Tax and Other Ratios
Effective Tax Rate
 0.00 ― 0.00 0.00 0.00
Revenue Per Share
 0.00 ― 0.00 0.00 0.00
Net Income Per Share
 -2.93 ― -5.59 -0.42 -0.22
Tax Burden
 0.90 ― 1.00 1.00 0.84
Interest Burden
 1.14 ― 0.79 0.99 0.92
Research & Development to Revenue
 0.00 ― 0.00 0.00 0.00
SG&A to Revenue
 0.00 ― 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 ― 0.00 0.00 0.00
Income Quality
 0.87 ― 0.90 0.88 0.95
Currency in CAD